Liver enzyme variability and risk of heart disease and mortality: A nationwide population-based study.

Liver International : Official Journal of the International Association for the Study of the Liver
Eun Ju ChoSu Jong Yu

Abstract

Liver enzymes, such as alanine aminotransferase (ALT), aspartate aminotransferase (AST) and γ-glutamyltransferase (GGT), have been suggested as surrogate markers of various cardiovascular diseases. However, previous studies assessed liver enzymes only once at baseline. We investigated the association between liver enzyme variability and the risk of mortality and cardiovascular outcomes in general population. A total of 6 496 271 subjects participating in ≥3 health examinations within the previous 5 years including the index year (2009-2010) were included. Variability was measured using variability independent of the mean. Cox proportional hazard models adjusting demographic factors, comorbidities, blood pressure, total cholesterol, glomerular filtration rate and baseline liver enzyme level were used. During a median follow-up of 6 years, there were 106 413 deaths (1.6%), 53 385 myocardial infarctions (MI, 0.8%), 65 143 atrial fibrillations (AF, 1.0%) and 50 139 congestive heart failures (CHF, 0.7%). High variability in AST, ALT and GGT was associated with a higher risk for all-cause mortality, MI, AF and CHF. The degree of association was largest for GGT variability. For the highest quartile of GGT variability relative to the l...Continue Reading

References

Feb 8, 2005·Atherosclerosis·Duk-Hee Lee, David R Jacobs
Mar 5, 2008·Annals of Internal Medicine·Mariana LazoJeanne M Clark
Nov 10, 2010·Nature Reviews. Cardiology·Anh L BuiGregg C Fonarow
Dec 22, 2012·European Heart Journal·Johann Auer
Sep 23, 2014·BMJ : British Medical Journal·Naveed SattarDavid Preiss
Jan 28, 2015·World Journal of Gastroenterology : WJG·Silvia Sookoian, Carlos J Pirola
Dec 15, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Aynur Unalp-Arida, Constance E Ruhl
Aug 28, 2016·European Heart Journal·Paulus KirchhofUNKNOWN ESC Scientific Document Group
Oct 1, 2016·American Journal of Hypertension·Yuichiro Yano
Aug 8, 2018·Diabetes Care·Jin J ZhouUNKNOWN VADT Investigators
Sep 5, 2018·BMC Cardiovascular Disorders·Jorge Navarro-PérezUNKNOWN ESCARVAL STUDY GROUP

❮ Previous
Next ❯

Citations

Jun 2, 2020·World Journal of Gastroenterology : WJG·Panyavee PitisuttithumSombat Treeprasertsuk

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.